Metropolitan Life Insurance Company (MetLife)’s CBRE Group CBRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,994
Closed -$1.17M 373
2024
Q1
$1.17M Sell
11,994
-412
-3% -$37K 0.05% 304
2023
Q4
$1.15M Sell
12,406
-412
-3% -$32K 0.05% 292
2023
Q3
$947K Sell
12,818
-727
-5% -$60.3K 0.05% 304
2023
Q2
$1.09M Sell
13,545
-586
-4% -$43.9K 0.05% 307
2023
Q1
$1.03M Sell
14,131
-4,142
-23% -$338K 0.05% 315
2022
Q4
$1.41M Sell
18,273
-507
-3% -$37.4K 0.06% 291
2022
Q3
$1.27M Sell
18,780
-562
-3% -$44.5K 0.06% 295
2022
Q2
$1.42M Sell
19,342
-960
-5% -$77.3K 0.06% 290
2022
Q1
$1.86M Sell
20,302
-18,409
-48% -$1.79M 0.07% 278
2021
Q4
$4.2M Sell
38,711
-1,573
-4% -$161K 0.06% 271
2021
Q3
$3.92M Sell
40,284
-1,356
-3% -$126K 0.06% 267
2021
Q2
$3.57M Buy
41,640
+229
+0.6% +$19.5K 0.05% 297
2021
Q1
$3.28M Sell
41,411
-2,029
-5% -$143K 0.05% 326
2020
Q4
$2.72M Sell
43,440
-1,264
-3% -$71.4K 0.04% 364
2020
Q3
$2.1M Sell
44,704
-2,009
-4% -$91.7K 0.04% 401
2020
Q2
$2.11M Sell
46,713
-8,636
-16% -$372K 0.04% 385
2020
Q1
$2.09M Sell
55,349
-466
-0.8% -$25.8K 0.04% 367
2019
Q4
$3.42M Sell
55,815
-1,215
-2% -$67.3K 0.05% 306
2019
Q3
$3.02M Buy
57,030
+2,119
+4% +$111K 0.05% 316
2019
Q2
$2.82M Buy
54,911
+2,763
+5% +$137K 0.05% 352
2019
Q1
$2.58M Sell
52,148
-1,935
-4% -$90.8K 0.05% 352
2018
Q4
$2.17M Buy
54,083
+786
+1% +$32.5K 0.04% 380
2018
Q3
$2.35M Buy
53,297
+67
+0.1% +$3.19K 0.04% 429
2018
Q2
$2.54M Buy
53,230
+1,344
+3% +$63.6K 0.04% 395
2018
Q1
$2.45M Buy
51,886
+280
+0.5% +$12.8K 0.03% 418
2017
Q4
$2.23M Sell
51,606
-96,438
-65% -$4M 0.03% 478
2017
Q3
$5.61M Sell
148,044
-2,563
-2% -$94.3K 0.04% 517
2017
Q2
$5.48M Sell
150,607
-10,351
-6% -$360K 0.04% 519
2017
Q1
$5.6M Sell
160,958
-2,039
-1% -$68.2K 0.04% 516
2016
Q4
$5.13M Sell
162,997
-2,861
-2% -$82.8K 0.04% 554
2016
Q3
$4.64M Buy
165,858
+1,277
+0.8% +$36.4K 0.03% 578
2016
Q2
$4.36M Buy
164,581
+14
+0% +$409 0.03% 595
2016
Q1
$4.74M Sell
164,567
-2,189
-1% -$60.2K 0.04% 541
2015
Q4
$5.77M Sell
166,756
-1,619
-1% -$57.1K 0.04% 429
2015
Q3
$5.39M Buy
168,375
+2,382
+1% +$84.5K 0.04% 467
2015
Q2
$6.14M Buy
165,993
+1,584
+1% +$60.1K 0.04% 440
2015
Q1
$6.36M Sell
164,409
-1,987
-1% -$68.5K 0.05% 413
2014
Q4
$5.7M Sell
166,396
-1,564
-0.9% -$50K 0.04% 473
2014
Q3
$5M Sell
167,960
-2,645
-2% -$83.1K 0.04% 511
2014
Q2
$5.47M Sell
170,605
-7,791
-4% -$225K 0.04% 496
2014
Q1
$4.89M Sell
178,396
-2,413
-1% -$65.1K 0.03% 552
2013
Q4
$4.75M Sell
180,809
-3,170
-2% -$75.4K 0.03% 541
2013
Q3
$4.25M Sell
183,979
-17,259
-9% -$400K 0.03% 555
2013
Q2
$4.7M Buy
+201,238
New +$4.79M 0.04% 472

Other funds holding CBRE

Metropolitan Life Insurance Company (MetLife)'s CBRE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CBRE Group (CBRE) in Q2 2024, closing a stake of 11,994 shares — an estimated $1.17M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CBRE in Q2 2013 and held it in 44 quarters. The position peaked at $6.36M in Q1 2015. 782 funds tracked by Wall St. Rank hold CBRE as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CBRE Group position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 11,994 CBRE Group shares in Q2 2024, an estimated $1.17M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CBRE Group in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CBRE Group position peaked at $6.36M in Q1 2015.
  • 782 funds tracked by Wall St. Rank held CBRE Group as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.